Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Reduced-Intensity Versus Myeloablative Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Myelodysplastic Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials & Cohort Studies

Arshia Akbar, MDMBBS, Zunairah Shah, MBBS, Muhammad Ali Aziz, MD, Muhammad Yasir Anwar, Saman Bahram, Waqas Khan, Zahoor Ahmed, MD, Qasim Khurshid, MD, Abdul Jabbar Dar, MD, Anum Javaid, MD, Neelam Asghar, Harsh Patel, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 25–26.

https://doi.org/10.1182/blood-2020-138771

Published: 2020

Journal Articles

Efficacy of Daratumumab Based Regimens Compared to Standard of Care for Transplant Ineligible Newly Diagnosed Multiple Myeloma in Phase III Clinical Trials: A Meta-Analysis

Zahoor Ahmed, MD, Karun Neupane, MBBS,MD, Rabia Ashraf, MBBS, MD, Amna Khan, MBBS, MD, Moazzam Shahzad, MD, Muhammad Salman Faisal, MD MBBS, Sana Irfan Khan, MD, Abdul Rafae, MD, Arshia Akbar, MDMBBS, Ahsan Wahab, MD, Hamid Ehsan, MDMBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 32–33.

https://doi.org/10.1182/blood-2020-137141

Published: 2020

Journal Articles

A Systematic Review of Daratumumab Based Four Drug Regimen for Newly Diagnosed Multiple Myeloma in Phase III Clinical Trials

Karun Neupane, MBBS,MD, Zahoor Ahmed, MD, Amna Khan, MBBS, MD, Rabia Ashraf, MBBS, MD, Moazzam Shahzad, MD, Shaha Nabeel, MD, Arshia Akbar, MDMBBS, Saad Javed, MD, Syed Maaz Abdullah, MBBS, Unaiza Faizan, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 36–37.

https://doi.org/10.1182/blood-2020-138466

Published: 2020

Journal Articles

Risk of Thyroid Dysfunctions with Use of Immune Checkpoint Inhibitors: A Meta-Analysis of Randomized Controlled Trials

Muhammad Yasir Anwar, Unaiza Faizan, MD, Muhammad Khawar Sana, MD, Muhammad Ans Sharif, MBBS, Ali Anjum, MD, Hafsa Tahir Chaudry, MBBS, Sara Ashraf, MD, Muhammad Ashar Ali, MD, Arshia Akbar, MDMBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 14.

https://doi.org/10.1182/blood-2020-136972

Published: 2020

Journal Articles

Emerging Role of Adoptive T Cell Therapy for EBV Induced Nasopharyngeal Carcinoma (NPC) - a Systematic Review

Muhammad Saad Farooqi, MDMBBS, Unaiza Faizan, MD, Saad Ur Rahman, MBBS, Hassaan Imtiaz, MD, Muhammed Hamza Arshad, MD, Arafat Ali Farooqui, MD, Zahoor Ahmed, MD, Muhammad Ali Aziz, MD, Ali Jaan, MD, Ali Shahbaz Baloch, MD, Naurez Qasim, MD, Arshia Akbar, MDMBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 18–19.

https://doi.org/10.1182/blood-2020-137139

Published: 2020

Journal Articles

CD-19 Specific CAR-T Cell Therapy in Relapsed/Refractory ALL in Pediatrics and Young Adults; Safety and Efficacy Outcomes: A Systematic Review and Meta-Analysis

Sobia Aamir, MDFCPS, Muhammad Ashar Ali, MD, Sana Irfan Khan, MD, Abdul Jabbar Dar, MD, Farhan Khalid, MBBS, Muhammad Yasir Anwar, Muhammad Tayyeb, MD, Anam Khan, Atif Irfan Khan, MD, Syeda Sabeeka Batool, MBBS, MD, Arshia Akbar, MDMBBS, Seemal Iftikhar, MD, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 10–11.

https://doi.org/10.1182/blood-2020-134059

Published: 2020

Journal Articles

A Systemic Review on Efficacy of Ibrutinib-Based Regimens for the Treatment of Waldenstrom Macroglobulinemia

Qasim Khurshid, MD, Abdul Jabbar Dar, MD, Muhammad Ali Mirza, MD, Muhaddis Ejaz Ahmad, MD, Ali Jaan, MD, Sobia Aamir, MDFCPS, Syed Maaz Abdullah, MBBS, Richi Kashyap, MD, Israr Khan, Waqas Khan, Sundas Ali, Arshia Akbar, MDMBBS, Saad Javed, MD, Fazeel Qamar, MBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 8–9.

https://doi.org/10.1182/blood-2020-138765

Published: 2020

Journal Articles

A Systematic Review and Meta-Analysis of Luspatercept for Anemia Treatment in Low Risk Myelodysplastic Syndrome with Ring Sideroblast Subtype in Phase II and Phase III Clinical Trials

Arshia Akbar, MDMBBS, Waqas Khan, Zunairah Shah, MBBS, Muhammad Yasir Anwar, Muhammad Ali Aziz, MD, Zahoor Ahmed, MD, Muhammad Saad Farooqi, MDMBBS, Ali Shahbaz Baloch, MD, Mydah Sajid Hashmi, MD, Qasim Khurshid, MD, Abdul Jabbar Dar, MD, Saman Bahram, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 40–41.

https://doi.org/10.1182/blood-2020-137152

Published: 2020

Journal Articles

Rituximab and Cyclophosphamide Based Regimens for Treatment of Waldensterom Macroglobulemia, Lessons from Clinical Literature: A Systemic Review

Qasim Khurshid, MD, Abdul Jabbar Dar, MD, Muhammad Ali Mirza, MD, Muhaddis Ejaz Ahmad, MD, Sobia Aamir, MDFCPS, Richi Kashyap, MD, Syed Maaz Abdullah, MBBS, Muhammad Saad Farooqi, MDMBBS, Israr Khan, Arshia Akbar, MDMBBS, Waqas Khan, Muhammad Tayyeb, MD, Sundas Ali, Saad Javed, MD, Fazeel Qamar, MBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 10–11.

https://doi.org/10.1182/blood-2020-138964

Published: 2020

Journal Articles

Efficacy and Safety of Isatuximab in Relapsed Refractory Multiple Myeloma: A Systematic Review

Mydah Sajid Hashmi, MD, Ali Jaan, MD, Muhammad Ans Sharif, MBBS, Summera Aziz, Zahoor Ahmed, MD, Karun Neupane, MBBS,MD, Muhammad Salman Faisal, MD MBBS, Israr Khan, Arshia Akbar, MDMBBS, Faiz Anwer, MD

Blood (2020) 136 (Supplement 1): 8–9.

https://doi.org/10.1182/blood-2020-136079

Published: 2020

Journal Articles

Efficacy and Toxicity of Lenalidomide for Treatment of Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis

Sravanthi Kotapati, MBBS, Insija Ilyas Selene, MBBS, Madeeha Shafqat, Syeda Fatima Hassan, MBBS, Zunairah Shah, MBBS, Arshia Akbar, MD, Owais ur Rehman, MBBS, Tariq Iqtidar Sadiq Syed, MD, Marium Ghani, MBBS, Syed Maaz Abdullah, MBBS, Maimoona Khan, MBBS, Jemin Aby Jose, MD, Faiz Anwer, MD

Blood (2019) 134 (Supplement_1): 5488.

https://doi.org/10.1182/blood-2019-129733

Published: 2019

Journal Articles

Bispecific T-Cell Engager (BiTE) Antibody Based Immunotherapy for Treatment of Relapsed Refractory Multiple Myeloma (RRMM): A Systematic Review of Preclinical and Clinical Trials

Zunairah Shah, MBBS, Mustafa Nadeem Malik, MD, Syeda Sabeeka Batool, MBBS, MD, Sravanthi Kotapati, MBBS, Aisha Akhtar, MBBS, Owais ur Rehman, MBBS, Marium Ghani, MBBS, Maryam Sadiq, MBBS, Arshia Akbar, MD, Aqsa Ashraf, MBBS, Arafat Ali Ali Farooqui, MD, Muhammad Abdullah Yousaf, MBBS, MD, Muhaddis Ejaz Ahmad, MD, Hafiz Muhammad Fazeel, MBBS, Faiz Anwer, MD

Blood (2019) 134 (Supplement_1): 5567.

https://doi.org/10.1182/blood-2019-129652

Published: 2019

Journal Articles

Role of B-Cell Maturation Antigen (BCMA) Targeted Immunotherapies in Relapsed and Refractory Multiple Myeloma- a Systematic Review

Zunairah Shah, MBBS, Syeda Sabeeka Batool, MBBS, MD, Hafiz Muhammad Fazeel, MBBS, Mustafa Nadeem Malik, MD, Maryam Sadiq, MBBS, Syeda Fatima Hassan, MBBS, Tariq Iqtidar Sadiq Syed, MD, Syed Maaz Abdullah, MBBS, Nisma Javed, MBBS, Aqsa Ashraf, MD, Arafat Ali Ali Farooqui, MD, Muhammad Abdullah Yousaf, MBBS, MD, Muhaddis Ejaz Ahmad, MD, Marium Ghani, MBBS, Arshia Akbar, MD, Faiz Anwer, MD

Blood (2019) 134 (Supplement_1): 5597.

https://doi.org/10.1182/blood-2019-131849

Published: 2019

Journal Articles

Sequencing Therapy for Elderly Chronic Lymphocytic Leukemia Patients in the Era of Novel Therapies: An Overview of Randomized Clinical Trials

Malik Qistas Ahmad, MD MBBS, Chaudhry Saad Sohail, MD, Muhammad Yasir, MD, Muhammad Junaid Tariq, MD, Arshia Akbar, MD, Muhammad Jahanzeb Khalil, MD, Muhammad Usman, MD, Muhammad Asad Fraz, MD, Muhammad Umair Jahngir, Ali Younas Khan, MD, Awais Ijaz, MD, Ceren Durer, MD, Seren Durer, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5559.

https://doi.org/10.1182/blood-2018-99-117084

Published: 2018

Journal Articles

Beyond JAK2 Inhibitors: A Systematic Review of Management Strategies for Myelofibrosis

Ali Younas Khan, MD, Nimra Iftikhar, MD, Awais Ijaz, MD, Muhammad Junaid Tariq, MD, Faiza Jamil, MD, Arshia Akbar, MD, Anum Qureshi, Jemin Aby Jose, MD, Ahmad Kamal, MD, Muhammad Abu Zar, MD, Madeeha Shafqat, Insija Ilyas Selene, MBBS, Shehroz Aslam, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 5484.

https://doi.org/10.1182/blood-2018-99-115867

Published: 2018

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Reduced-Intensity Versus Myeloablative Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Myelodysplastic Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials & Cohort Studies

Efficacy of Daratumumab Based Regimens Compared to Standard of Care for Transplant Ineligible Newly Diagnosed Multiple Myeloma in Phase III Clinical Trials: A Meta-Analysis

A Systematic Review of Daratumumab Based Four Drug Regimen for Newly Diagnosed Multiple Myeloma in Phase III Clinical Trials

Risk of Thyroid Dysfunctions with Use of Immune Checkpoint Inhibitors: A Meta-Analysis of Randomized Controlled Trials

Emerging Role of Adoptive T Cell Therapy for EBV Induced Nasopharyngeal Carcinoma (NPC) - a Systematic Review

CD-19 Specific CAR-T Cell Therapy in Relapsed/Refractory ALL in Pediatrics and Young Adults; Safety and Efficacy Outcomes: A Systematic Review and Meta-Analysis

A Systemic Review on Efficacy of Ibrutinib-Based Regimens for the Treatment of Waldenstrom Macroglobulinemia

A Systematic Review and Meta-Analysis of Luspatercept for Anemia Treatment in Low Risk Myelodysplastic Syndrome with Ring Sideroblast Subtype in Phase II and Phase III Clinical Trials

Rituximab and Cyclophosphamide Based Regimens for Treatment of Waldensterom Macroglobulemia, Lessons from Clinical Literature: A Systemic Review

Efficacy and Safety of Isatuximab in Relapsed Refractory Multiple Myeloma: A Systematic Review

Efficacy and Toxicity of Lenalidomide for Treatment of Chronic Lymphocytic Leukemia: A Systematic Review and Meta-Analysis

Bispecific T-Cell Engager (BiTE) Antibody Based Immunotherapy for Treatment of Relapsed Refractory Multiple Myeloma (RRMM): A Systematic Review of Preclinical and Clinical Trials

Role of B-Cell Maturation Antigen (BCMA) Targeted Immunotherapies in Relapsed and Refractory Multiple Myeloma- a Systematic Review

Sequencing Therapy for Elderly Chronic Lymphocytic Leukemia Patients in the Era of Novel Therapies: An Overview of Randomized Clinical Trials

Beyond JAK2 Inhibitors: A Systematic Review of Management Strategies for Myelofibrosis

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only